Encapsulation of ruthenium(II) uracil compounds into chitosan (CS)-polyvinyl alcohol (PVA) electrospun nanofibers: Nanofabrication, characterization, drug release, and in vitro anti-diabetic studies
Open Access
- 21 April 2026
- journal article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 265, 115733
Abstract
No abstract availableKeywords
Funding Information
- South African Agency for Science and Technology Advancement (120834)
- South African Agency for Science and Technology Advancement (114737)
- National Research Foundation
- Inyuvesi Yakwazulu-Natali
This publication has 59 references indexed in Scilit:
- Nanocarrier-based Drug Delivery Systems: A Way to Effective Diabetes ManagementBioNanoScience, 2025
- Polymer nanocomposites in diabetes management: advances in biosensors and drug delivery systemsDiscover Materials, 2025
- Anti‐Amyloid Aggregation and Anti‐Hyperglycemic Activities of Novel Ruthenium Uracil Schiff Base CompoundsChemMedChem, 2024
- Altering the characterization of nanofibers by changing the electrospinning parameters and their application in tissue engineering, drug delivery, and gene delivery systemsPolymers for Advanced Technologies, 2021
- Guidelines for cell viability assaysFood Frontiers, 2020
- Amelioration of risk factors associated with diabetic nephropathy in diet-induced pre-diabetic rats by an uracil-derived diimine ruthenium(II) compoundBiomedicine & Pharmacotherapy, 2020
- Recent progress in drug deliveryActa Pharmaceutica Sinica B, 2019
- Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cellsArchives of Toxicology, 2017
- Central Regulation of Glucose HomeostasisComprehensive Physiology, 2017
- A bioluminescent assay for measuring glucose uptakeAnalytical Biochemistry, 2016